Advanced CRISPR/Cas-based genome editing services for vegetable crops using base editors and prime editors to achieve single or multiple nucleotide substitutions, deletions, and insertions. Enables production of transgene-free, gene-edited vegetables with improved quality, yield, disease resistance, and stress tolerance for field trials and commercial applications.
This offering leverages advanced CRISPR/Cas-based genome editing tools to introduce precise genetic modifications in vegetable crops, including single or multiple nucleotide substitutions, deletions, and insertions. The approach combines indel prediction, homology-dependent repair, base editing, and prime editing to develop transgene-free vegetables with improved agronomic traits such as superior quality, higher yield, disease resistance, and abiotic stress tolerance. These precisely edited crops are positioned for field trials and commercial deployment under favorable regulatory frameworks for gene-edited products.
Editing tools and capabilities:
Crop experience:
Track record:
The underlying technologies have been validated through peer-reviewed publications and demonstrated across multiple crop species over the past decade. Base editing and prime editing have achieved 40-50% editing efficiency in rice, and the lab has produced gene-edited rice cultivars ready for field trials. The gene-edited mushroom previously served as a regulatory precedent for USDA approval of gene-edited crops. The technology is ready for application to new vegetable crop targets, with established protocols for transformation and editing in solanaceous and cruciferous plant families.
Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.